Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$SLXN

Silexion Therapeutics Corp Ordinary Shares

XNAS

$1.72-30.00%$0.7350Prev $2.45LIVE Full chart Live alerts
No recent price bars, the chart lights up when SLXN starts printing.

Why is SLXN down today? It is at $1.72 (-30.00%), and our scanner flagged it 5 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SLXN spikes, and full due diligence on SLXN — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $SLXN alerts the moment volume spikes

Our scanner flagged $SLXN 5 times in the last 30 days. Create a free account to track $SLXN, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$1.72
Change today
-30.00%
Previous close
$2.45
52-week range
$2.20 – $223.60
Valuation & dividend
Market cap
$3M
Ownership & volume
Shares outstanding
3.3M
SEC · as of 2026-03-10
Insider ownership
1.3%
DEF 14A · 2026-06-16
Institutional own.
0.34%
Total held
1.7%
Tradeable float
3.3M
98% of shares · after 1% insiders + 0% institutions
Short interest
13K
▼ -5% vs prior · as of 2026-07-15
Short % of float
0.4%
Days to cover
1.0d
Avg daily volume
175K
Next earnings
Aug 11 · in 13d
Classification
Exchange
XNAS
Relative volumevs this time of day
5mthin
1.2x
15mthin
1.8x
1hthin
0.8x
1D
13x

Get free SLXN + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $SLXN down today?

5 alerts today11.6x RVOL

SLXN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on SLXN today, peaking at 11.6x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.

Likely catalystCharter / Bylaw Change · Shareholder Vote, from the latest SEC filing. Read it →
Why is $SLXN moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile⚡ Ultra-low float · 3.3M shNot shortableNo SSRBorrow via Alpaca · SSR from Reg SHO 201

Insiders

Insiders buying3 buys, 0 sells last 3 months (3/0 over 12 months)
Show 3 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Hadar Ilan
Officer
Acquired (grant/award)+10K
0.3% of company
added 100%17Kn/aJun 4, 26
Horenshtein Hadar Mirit
Officer
Acquired (grant/award)+8K
0.2% of company
added 100%13Kn/aJun 4, 26
Shirvan Mitchell
Officer
Acquired (grant/award)+6K
0.2% of company
added 100%9Kn/aJun 4, 26

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

$SLXN is down 30.0% today and has an active shelf on file. See who may be selling into moves →

Dilution watch

Active shelf

At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $SLXN runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$SLXN Sentiment

Neutral
Bearish56Bullish
📰 News: 4 bull · 0 bearToday: -30.0%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$SLXN Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 1h ago 2.8× RVOL
SLXN hit 2.807x RVOL at 9:17 AM ET
at $1.90
Alert· 3h ago 3.1× RVOL
SLXN hit 3.150x RVOL at 7:48 AM ET
at $2.15
Alert· 3h ago +24.59%
$SLXN moved +24.59% (~15m high-low range 24.59%) (Level 5) at 7:05 AM ET
at $2.67
Alert· 3h ago +6.56%
$SLXN moved +6.56% in 1 min (Level 5) at 7:00 AM ET
at $2.60
Alert· 3h ago 11.6× RVOL
SLXN hit 11.557x RVOL at 7:00 AM ET
at $2.55
News· SEC EDGAR· 7d ago
Silexion Therapeutics Corp filed an 8-K: Charter / Bylaw Change, Shareholder Vote
News· SEC EDGAR· 61d ago
Silexion Therapeutics Corp filed an 8-K: Shareholder Rights Change, Charter / Bylaw Change, Other Material Event
News· SEC EDGAR· 64d ago
Silexion Therapeutics Corp filed an 8-K: Other Material Event
News· SEC EDGAR· 70d ago
Silexion Therapeutics Corp filed a Annual report (10-K/A)
News· GlobeNewswire Inc.· 77d ago Bullish
Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center
News· GlobeNewswire Inc.· 239d ago Bullish
Silexion Therapeutics Receives Positive Feedback from German Health Authority on Design of Phase 2/3 Clinical Trial in Pancreatic Cancer
News· GlobeNewswire Inc.· 259d ago Bullish
Silexion Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
News· GlobeNewswire Inc.· 321d ago Bullish
Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204’s Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

SLXN stock FAQ

Why is $SLXN down today?

SLXN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on SLXN today, peaking at 11.6x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.

What is the SLXN stock price today?

SLXN last traded at $1.72, down 30.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

When does SLXN report earnings?

Silexion Therapeutics Corp Ordinary Shares (SLXN) is next expected to report earnings on Tuesday, August 11, 2026, about 13 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.

Where can I see live SLXN alerts?

The SLXN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SLXN 5 times in the last 30 days.

What exchange is SLXN on?

SLXN (Silexion Therapeutics Corp Ordinary Shares) trades on XNAS, with a market cap of about $3M.

Is SLXN good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SLXN for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.